Category: Latest News
-
Diageo shares rise on stronger-than-expected FY25 results and solid guidance
Shares of Diageo (NYSE:DEO) climbed nearly 3% in London on Tuesday after the global spirits giant delivered better-than-anticipated results for its fiscal year ending June 2025, coupled with a confident outlook for operating profit growth. The company reported net sales of $20.25 billion, essentially flat on a reported basis but up 1.7% organically. Both figures…
-
Agilon Health shares plunge after Q2 miss, leadership shakeup, and suspended guidance
Agilon Health Inc. (NYSE:AGL) saw its stock plummet over 25% in pre-market trading Tuesday after reporting second-quarter results that missed expectations and withdrawing its full-year guidance amid executive turnover and mounting industry pressures. The healthcare provider reported a quarterly net loss of $0.25 per share, more than double the analyst consensus estimate of $0.11. Revenue…
-
Amneal Pharmaceuticals lifts annual outlook after strong Q2, Specialty segment drives growth
Amneal Pharmaceuticals (NASDAQ:AMRX) reported better-than-expected second-quarter results on Tuesday, as strength in its Specialty division helped lift earnings, prompting the company to raise its full-year profit guidance. The company’s stock rose 1.13% in after-hours trading following the release. Adjusted earnings for the quarter came in at $0.25 per share, beating the $0.17 analyst consensus and…
-
Atkore beats Q3 estimates, reaffirms annual targets as CEO announces retirement
Atkore Inc. (NYSE:ATKR) posted stronger-than-expected third-quarter results on Tuesday, with adjusted earnings of $1.63 per share surpassing the consensus estimate of $1.56. Revenue came in slightly above forecasts at $735 million, just ahead of the expected $734.2 million. While total revenue declined 10.6% from the same quarter last year—largely due to lower average selling prices…
-
Ball Corporation tops Q2 forecasts as global aluminum packaging demand grows
Ball Corporation (NYSE:BALL) reported better-than-expected second quarter results on Tuesday, buoyed by a 4.1% uptick in worldwide shipments of aluminum packaging and solid contributions from its international business units. The company reported adjusted earnings per share of $0.90, outpacing analysts’ projection of $0.87. Revenue came in at $3.34 billion, well ahead of the $3.11 billion…
-
Ryanair Sees July Passenger Numbers Rise 2.5% to 20.7 Million
On Tuesday, Ryanair (NASDAQ:RYAAY)revealed that passenger traffic for July climbed 2.5%, reaching a total of 20.7 million travelers with a robust 96% load factor. The Irish low-cost airline is on pace to hit its fiscal 2026 target of 206 million passengers, in line with current market forecasts. Market analysts expect Ryanair to carry around 61…
-
BP’s Q2 earnings beat forecasts despite lower profits compared to last year
BP (NYSE:BP) reported on Tuesday second-quarter profits that surpassed analyst estimates, even as year-on-year earnings declined amid ongoing volatility in global oil and gas markets. The company’s underlying replacement cost (RC) profit rose to $2.4 billion for the quarter, improving from $1.4 billion in the first quarter, driven by better performance across its key segments.…
-
Palantir shares jump 5% premarket as AI demand drives upgraded outlook
Shares of Palantir Technologies (NASDAQ:PLTR) climbed over 5% in premarket trading following the company’s announcement of raised full-year guidance, propelled by robust demand from government and corporate clients for its AI-powered solutions. The U.S. government’s push to expand artificial intelligence adoption, alongside the Pentagon’s increased purchases from “non-traditional” software vendors, has boosted growth for the…
-
Fresenius Medical Care posts Q2 revenue growth despite headwinds
Fresenius Medical Care (NYSE:FMS) on Tuesday announced second-quarter 2025 revenue of €4,792 million, aligning closely with consensus expectations of €4,750 million and marking a 5% increase on a constant currency basis. Adjusted EBIT reached €476 million, slightly trailing the consensus forecast of €492 million by about 3%. The company cited a severe flu season and…
-
Hims and Hers shares drop after revenue falls short amid GLP-1 scrutiny
Shares of Hims and Hers Health (NYSE:HIMS) slid 14% in premarket trading following the telehealth company’s announcement of second-quarter revenue that fell short of Wall Street expectations, amid increasing legal and regulatory scrutiny surrounding its compounded weight-loss drug offerings. Quarterly revenue rose to $544.8 million but missed the consensus forecast of $549.9 million. Investor concerns…